ストックスクリーナーアプリを入手
2.13
0.71%
0.015
前日終値:
$2.115
開ける：
$2.09
24時間の取引高:
8,859
Relative Volume:
0.29
時価総額：
$78.39M
収益：
$24.38M
当期純損益:
$-53.95M
株価収益率:
-0.8623
EPS:
-2.47
ネットキャッシュフロー:
$-23.31M
1週間 パフォーマンス:
+3.90%
1か月 パフォーマンス:
+17.68%
6か月 パフォーマンス:
-34.46%
1年 パフォーマンス:
-46.75%
1日の値動き範囲:
$2.09
$2.25
1週間の範囲:
$1.76
$2.41
52週間の値動き範囲:
$1.61
$5.12
Elutia Inc Stock (ELUT) Company Profile
ELUT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.13 | 84.29M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 開始されました | Cowen | Outperform |
| 2020-11-02 | 開始されました | Piper Sandler | Overweight |
| 2020-11-02 | 開始されました | Truist | Buy |
Elutia Inc (ELUT) 最新ニュース
Elutia Inc. Stock Analysis and ForecastStrongest growth potential - jammulinksnews.com
Is Elutia Inc. a good long term investmentExceptional earning trajectories - Autocar Professional
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
What drives Elutia Inc. stock priceDynamic portfolio growth - jammulinksnews.com
What analysts say about Elutia Inc. stockFree Investment Risk Control - jammulinksnews.com
MSPRW Stock Analysis and ForecastExceptional market positioning - Jammu Links News
What analysts say about FatPipe Inc. stockGame-changing returns - jammulinksnews.com
What drives Middlesex Water Company stock priceSkyrocketing profit margins - jammulinksnews.com
Best Growth Stocks Stock Market Research ExpertsSkyrocketing investment returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockMassive wealth growth - jammulinksnews.com
Why Elutia Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
How Elutia Inc. stock performs during market volatilityFree Expert Investment Advice - Newser
What makes Elutia Inc. stock price move sharplyLow Risk Trading Ideas - Newser
Elutia (NASDAQ:ELUT) Trading Down 2.5% – Here’s What Happened - Defense World
Elutia Inc. Announces Promising Study Results for EluPro BioEnvelope in Improving Healing Outcomes for Cardiac Implantable Electronic Devices - Nasdaq
Clinical Study: Revolutionary Antibiotic Technology Shows Superior Results for Heart Implants - Stock Titan
Elutia announces publication of new study on CIED biologic envelope - TipRanks
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewswire
Medical Device Network Excellence Awards 2025: Elutia - Medical Device Network
Revenues Working Against Elutia Inc.'s (NASDAQ:ELUT) Share Price - simplywall.st
Elutia Inc. (NASDAQ:ELUT) Shares Purchased by Millennium Management LLC - Defense World
Citadel Advisors LLC Acquires Shares of 22,431 Elutia Inc. (NASDAQ:ELUT) - Defense World
Brokers Issue Forecasts for Elutia FY2026 Earnings - Defense World
Elutia (NASDAQ:ELUT) Shares Down 1% – Time to Sell? - Defense World
Aziyo Biologics Holds Annual Stockholders Meeting - TipRanks
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET By Investing.com - Investing.com South Africa
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET - Investing.com
Elutia v. Medtronic: Delaware court rules on indemnity and insurance obligations in FiberCel lawsuit - Insurance Business America
ELUT stock touches 52-week low at $1.61 amid market challenges By Investing.com - Investing.com South Africa
ELUT stock touches 52-week low at $1.61 amid market challenges - Investing.com India
Elutia Inc. Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro Testing Method - marketscreener.com
Elutia announces publication of article on measuring antibiotic release - TipRanks
Elutia (ELUT) Innovates with New Antibiotic Release Method | ELUT Stock News - GuruFocus
Revolutionary Drug Testing Method Cuts Medical Device Development Time from 14 Days to Just 30 Hours - Stock Titan
FY2025 EPS Estimates for Elutia Lifted by Cantor Fitzgerald - Defense World
Lake Street Capital Has Lowered Expectations for Elutia (NASDAQ:ELUT) Stock Price - Defense World
Elutia (ELUT) Price Target Reduced by Lake Street | ELUT Stock N - GuruFocus
Elutia (ELUT) Stock: Lake Street Adjusts Price Target | ELUT Sto - GuruFocus
Elutia (ELUT) Stock: Lake Street Adjusts Price Target | ELUT Stock News - GuruFocus
Elutia (ELUT) Price Target Reduced by Lake Street | ELUT Stock News - GuruFocus
Elutia Q1 2025 slides: EluPro sales surge 84% amid overall revenue decline - Investing.com Nigeria
Elutia Inc (ELUT) Q1 2025 Earnings Call Highlights: Strategic Growth and Challenges in Transition - Yahoo Finance
Elutia Inc (ELUT) 財務データ
収益
当期純利益
現金流量
EPS
1.15%
0.17%
大文字化:
|
ボリューム (24 時間):